252 related articles for article (PubMed ID: 27515593)
1. NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
Untersteller K; Girerd N; Duarte K; Rogacev KS; Seiler-Mussler S; Fliser D; Rossignol P; Heine GH
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1978-1988. PubMed ID: 27515593
[TBL] [Abstract][Full Text] [Related]
2. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).
Mishra RK; Li Y; Ricardo AC; Yang W; Keane M; Cuevas M; Christenson R; deFilippi C; Chen J; He J; Kallem RR; Raj DS; Schelling JR; Wright J; Go AS; Shlipak MG;
Am J Cardiol; 2013 Feb; 111(3):432-8. PubMed ID: 23178053
[TBL] [Abstract][Full Text] [Related]
3. Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure.
Hinderliter AL; Blumenthal JA; O'Conner C; Adams KF; Dupree CS; Waugh RA; Bensimhon D; Christenson RH; Sherwood A
Am Heart J; 2008 Dec; 156(6):1191-5. PubMed ID: 19033018
[TBL] [Abstract][Full Text] [Related]
4. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
5. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.
Kalogeropoulos AP; Georgiopoulou VV; deFilippi CR; Gottdiener JS; Butler J;
JACC Cardiovasc Imaging; 2012 Feb; 5(2):131-40. PubMed ID: 22340818
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
7. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
Emrich IE; Brandenburg V; Sellier AB; Schauerte J; Wiedenroth J; Untersteller K; Lennartz CS; Seiler-Mussler S; Wagenpfeil S; Fliser D; Heine GH
Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
10. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.
Choi EY; Bahrami H; Wu CO; Greenland P; Cushman M; Daniels LB; Almeida AL; Yoneyama K; Opdahl A; Jain A; Criqui MH; Siscovick D; Darwin C; Maisel A; Bluemke DA; Lima JA
Circ Heart Fail; 2012 Nov; 5(6):727-34. PubMed ID: 23032197
[TBL] [Abstract][Full Text] [Related]
12. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
[TBL] [Abstract][Full Text] [Related]
13. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation.
Westhoff-Bleck M; Kornau F; Haghikia A; Horke A; Bertram H; Treptau J; Widder J; Bauersachs J; Brehm MU
Can J Cardiol; 2016 Oct; 32(10):1247.e29-1247.e36. PubMed ID: 26927857
[TBL] [Abstract][Full Text] [Related]
15. Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients.
Yamazaki M; Ogawa T; Tamei N; Ando Y; Nitta K
Heart Vessels; 2011 Jul; 26(4):421-7. PubMed ID: 21127887
[TBL] [Abstract][Full Text] [Related]
16. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study.
Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt P
J Hypertens; 2004 Aug; 22(8):1597-604. PubMed ID: 15257184
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
[TBL] [Abstract][Full Text] [Related]
20. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
